Moderna, Inc. vs NIO Inc. — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while NIO Inc. trades at $4.81 (market cap $12.55B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Moderna, Inc. is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | NIO | |
|---|---|---|
Market Cap | $23.60B | $12.55B |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $7.89 |
52-Week Low | $22.36 | $4.44 |
Enterprise Value | $19.70B | $11.78B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →